| Application no. and date | 16704468.4 (espacenet) (Federated) (European Patent Register), 20160111 | | Patent/reg. no. and date | DK/EP 3245217, 20191002 | | Publication date | 20171122 | | Priority no. and date | SE 1500018, 20150112 | | EP pub. no. and date |
EP 3245217 20171122 | | Effective date | | | Applicant/owner | Umecrine Cognition AB, Karolinska Institutet Science Park
Fogdevreten 2
171 65 Solna, SE | | Applicant ref. no. | P70557DK01 | | Inventor | BÄCKSTRÖM, Torbjörn, Sofiehemsvägen 73A
SE-907 38 Umeå, SE,
RAGAGNIN, Gianna, Jakob Grubbs väg 17
SE-903 55 UmeÃ¥, SE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/57 (2006.01) , A61P 25/00 (2006.01) , A61P 25/28 (2006.01) , C07J 41/00 (2006.01) | | Title | 3.ALFA.-ETHYNYL, 3.BETA.-HYDROXY-5.ALFA.-PREGNAN-20-OXIM TIL ANVENDELSE I BEHANDLINGEN AF CNS-FORSTYRRELSER | | Int. application no. | GB2016050059 | | Int. publication no. | WO2016113549 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
